It’s strangely beautiful, even though we’re talking about a dreaded pathogen.
A single injection protects monkey from HIV infections
It’s not exactly a vaccine, but it’s the next best thing.
Dormant, berserk antibodies could hold the key for HIV vaccine
Their nature makes them ideal against pathogens that hide from immune cells, such as HIV.
Russia on the brink of HIV crisis as AIDS denial runs rampant through the country
The country might be on the verge of a health crisis.
Computer simulation identifies HIV Achilles Heel, offering new avenue for treatment
It also showcases how powerful computer simulations can be in fighting viruses.
What’s the difference between HIV and AIDS
You shouldn’t use the two interchangeably.
Child in South Africa becomes HIV free
This could be a game changer.
Massive simulation of the HIV ‘shell’ reveals new vulnerabilities that we might exploit to eliminate the virus
It took two years on a supercomputer to simulate 1.2 microseconds in the life of the HIV capsid.
Scientists tie antibody escorts on white blood cells’ access points to stop HIV dead in its tracks
It’s more effective than welding a slab of steel on the Death Star’s thermal exhaust port.
Five HIV patients are now virus-free thanks to a new vaccine therapy — but success rate is low
The new therapy gives the body new tools to weed out the HIV virus without any other drugs — one man has been HIV-free for 7 months.
Medication prevents HIV/AIDS has 92% success rate, but people don’t know about it yet
If taken daily, the pills can reduce the risk of HIV infection by up to 92 percent.
Revolutionary HIV vaccine to be tested on 600 people next year
We may be zooming in on a vaccine.
NIH isolates new antibody which neutralizes 98% of HIV strains in lab trials
We’re getting closer to a cure.
Drugs clear HIV from British patient’s system, offering hope for a cure
Five UK universities working together hope to bring an end to HIV.
HIV took one of our best attempts at killing it, survived and became stronger in the process
They say what doesn’t kill you makes you stronger, and unfortunately, that seems to be the case for HIV viruses.
Countries most in need of HIV treatment are least able to afford it
One study estimates that over the next 35 years, nine African countries would have to spend $98 billion to $261 billion to buy drugs and prevent infections.
Genetic-scissor enzyme eliminates HIV completely in mice trials
A new gene-snipping enzyme was successful in removing strands of HIV genetic material in mice trials. If the enzyme can prove its reliability in human trials it might revolutionize how we fight the virus forever.
One in Eight HIV-positive Americans are not aware they’re carrying the virus
A new extensive report carried out by the Centers for Disease Control and Prevention (CDC) found approximately 1 in 8 Americans with human immunodeficiency disease (HIV) are unaware of their condition. Overall, that means 14 percent of undiagnosed cases among 1.2 million patients with HIV in the US. An undiagnosed population is the prime contributor to the spread of the disease. Clearly, there’s much room for improvement.
Anti-vaxxer bet $100,000 that scientists couldn’t prove measles exists. German court now orders man to pay up
Four years ago, a vocal anti vaccine activist and a biologist by training challenged not only established medical science, but common sense. The man in question, Stefan Lanka, offered $100,000 to anyone who could prove the measles virus exists. Yes, the virus that used to infect millions of children and young adults hilariously doesn’t exist in Lanka’s view. David Barden, a German doctor, took it upon himself to battle the windmills. He mailed Lanka the most up-to-date and comprehensive research on measles. Unsurprisingly, Lanka dismissed them, but the German court thought otherwise. To them, the existence of measles is obvious and ordered the man to pay up the $106,000 he had promised.
Pill reduces risk of HIV infection for gay men by 86%
Two new studies – both covering gay men, one in Britain and the other in France – were recently shared with the public boasting terrific results. In the trials, gay men were asked to take a drug called Truvada either daily or right before and after having sex. In an unlikely event of chance, both studies found a 86 percent reduction in new HIV infections among volunteers using Truvada. This suggests that the orally administered drug might be a lifeline in many HIV-ridden communities, considering 90% of all HIV cases could be prevented if those infected seek treatment.